Paying user area
Try for free
CVS Health Corp. pages available for free this week:
- Income Statement
- Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Long-term (Investment) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Common Stock Valuation Ratios
- Enterprise Value (EV)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Operating Profit Margin since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to CVS Health Corp. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Statement
12 months ended: | Revenues from customers | Operating income | Net income (loss) attributable to CVS Health |
---|---|---|---|
Dec 31, 2024 | |||
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 29, 2007 | |||
Dec 30, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).
The financial data presents a comprehensive view of the revenue, operating income, and net income trends over a period from 2005 through 2024. The analysis reveals several significant patterns and fluctuations throughout these years.
- Revenues from customers
- Revenues show a general upward trend throughout the entire period. Starting at approximately $37 billion in 2005, revenues increased steadily with some acceleration after 2007, reaching a peak exceeding $370 billion by 2024. Notable jumps occur particularly after 2014, with sharp revenue growth continuing through to 2024. This indicates robust expansion and possibly the impact of strategic initiatives or market growth during this timeframe.
- Operating income
- Operating income displays more volatility compared to revenues. Beginning at about $2 billion in 2005, it rose steadily until 2013, peaking at over $10 billion in 2016. Notably, there was a sharp decline in 2018, dropping to around $4 billion, which contrasts with the consistent revenue growth. After this dip, operating income recovered, hitting nearly $14 billion in 2019 and 2020, but declined again in 2022 and 2024. These fluctuations suggest periods of increased operating expenses or one-time costs affecting profitability despite growing revenues.
- Net income (loss) attributable to CVS Health
- Net income generally follows the trend of operating income but presents some irregularities. From about $1.2 billion in 2005, net income grows steadily, reaching over $6 billion by 2017. However, 2018 marks a significant loss with net income recorded as negative ($-594 million), indicating a challenging year possibly due to extraordinary charges or restructuring costs. Subsequent years show recovery with net income surpassing $8 billion in 2019 and remaining strong through 2021. A notable decline occurs again in 2022 and 2024, paralleling the dips in operating income. The pattern reflects exposure to periodic adverse events impacting overall profitability despite revenue growth.
In summary, while revenue exhibits consistent and strong growth over the analyzed period, operating income and net income display pronounced volatility with dips suggesting periods of operational challenges or extraordinary expenses. The divergence between continued revenue growth and fluctuating profitability metrics indicates areas where cost management and operational efficiency may have varied, affecting overall financial performance.
Balance Sheet: Assets
Current assets | Total assets | |
---|---|---|
Dec 31, 2024 | ||
Dec 31, 2023 | ||
Dec 31, 2022 | ||
Dec 31, 2021 | ||
Dec 31, 2020 | ||
Dec 31, 2019 | ||
Dec 31, 2018 | ||
Dec 31, 2017 | ||
Dec 31, 2016 | ||
Dec 31, 2015 | ||
Dec 31, 2014 | ||
Dec 31, 2013 | ||
Dec 31, 2012 | ||
Dec 31, 2011 | ||
Dec 31, 2010 | ||
Dec 31, 2009 | ||
Dec 31, 2008 | ||
Dec 29, 2007 | ||
Dec 30, 2006 | ||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).
The analysis of the provided financial data reveals several notable trends in asset composition over the examined period.
- Current Assets
- The current assets demonstrate a consistent upward trajectory from 2005 through 2024. Beginning at $8,393 million in 2005, there is a steady increase year-over-year, reaching $31,229 million by 2017. A more pronounced growth phase occurs after 2017, with current assets rising sharply to $45,243 million in 2018 and continuing to expand to $68,645 million by 2024. This suggests an expansion in short-term liquidity and potentially enhanced operational capacity or increased inventory and receivables over the years.
- Total Assets
- Total assets exhibit substantial growth with a particularly marked increase starting in 2007. From $15,283 million in 2005, total assets nearly quadruple by 2007 to $54,722 million, indicating significant asset acquisitions or revaluations during this period. Growth continues steadily until 2017, with a sharp rise thereafter, reaching $196,456 million in 2018. Subsequently, total assets continue to increase but at a moderated pace, culminating at $253,215 million in 2024. This pattern suggests large-scale investments or acquisitions took place especially around 2007 and 2018, dramatically increasing the asset base.
- Comparative Observations
- The proportion of current assets relative to total assets expands over time but with fluctuations reflecting changes in asset structure. The sharp rise in total assets in 2007 and 2018 corresponds with accelerated growth in current assets, although total assets growth is more pronounced, indicating growth in long-term assets or capital investments. The steady climb in both current and total assets implies ongoing business expansion and asset accumulation, underlying a possible strategic emphasis on scaling operations and strengthening asset backing.
Balance Sheet: Liabilities and Stockholders’ Equity
CVS Health Corp., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
Current liabilities | Total liabilities | Total debt | Total CVS Health shareholders’ equity | |
---|---|---|---|---|
Dec 31, 2024 | ||||
Dec 31, 2023 | ||||
Dec 31, 2022 | ||||
Dec 31, 2021 | ||||
Dec 31, 2020 | ||||
Dec 31, 2019 | ||||
Dec 31, 2018 | ||||
Dec 31, 2017 | ||||
Dec 31, 2016 | ||||
Dec 31, 2015 | ||||
Dec 31, 2014 | ||||
Dec 31, 2013 | ||||
Dec 31, 2012 | ||||
Dec 31, 2011 | ||||
Dec 31, 2010 | ||||
Dec 31, 2009 | ||||
Dec 31, 2008 | ||||
Dec 29, 2007 | ||||
Dec 30, 2006 | ||||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).
The analysis of the financial data over the years reveals notable trends in the company's liabilities, debt, and shareholders' equity.
- Current Liabilities
- The current liabilities have exhibited a consistent increasing trend from 2005 to 2024. Beginning at approximately 4.6 billion US dollars in 2005, current liabilities have grown substantially to about 84.6 billion US dollars in 2024. The increase is particularly pronounced after 2013, indicating heightened short-term obligations in recent years.
- Total Liabilities
- Total liabilities data is only available from 2016 onwards, showing a sharp rise from about 57 billion US dollars in 2016 to 177 billion US dollars in 2024. This escalation suggests substantial growth in total obligations, likely reflecting increased borrowing or other liabilities over this period.
- Total Debt
- Total debt rose significantly from 2.2 billion US dollars in 2005, peaking around 27.5 billion US dollars in 2015-2016. After this peak, debt peaked sharply again at over 73 billion US dollars in 2018, before steadily declining to approximately 52 billion in 2022. However, debt increased again to around 66 billion US dollars by 2024. This fluctuation indicates periods of heavy borrowing possibly for expansion or restructuring, followed by attempts at deleveraging, then rising again.
- Shareholders' Equity
- Shareholders’ equity initially increased from 8.3 billion US dollars in 2005 to above 37 billion US dollars by 2013, showing solid growth in net assets during the earlier part of the period. Post-2013, equity experienced a sharp rise peaking near 75 billion US dollars by 2021, indicating strong capital accumulation and retained earnings. There is a slight decline noted in 2022 and 2024, possibly suggesting share buybacks, dividend distributions, or losses impacting the equity base.
Overall, the company has shown substantial growth in both liabilities and shareholders' equity, with current liabilities and total debt showing notable increases, especially post-2013. The pattern of debt indicates strategic borrowing cycles. The steady growth in shareholders’ equity suggests a healthy expansion in net asset value, despite some fluctuations in recent years. These trends reflect a company possibly engaging in significant investment or expansion activities while managing its capital structure actively.
Cash Flow Statement
12 months ended: | Net cash provided by operating activities | Net cash used in investing activities | Net cash provided by (used in) financing activities |
---|---|---|---|
Dec 31, 2024 | |||
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 29, 2007 | |||
Dec 30, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).
- Operating Activities
- The net cash provided by operating activities shows an overall positive and increasing trend from 2005 through 2021, starting at $1,612 million in 2005 and peaking at $18,265 million in 2021. Despite some fluctuations, operating cash flow generally grew steadily over these years. However, after 2021, a decline is observed, with amounts decreasing to $16,177 million in 2022, $13,426 million in 2023, and further down to $9,107 million projected for 2024. This indicates a weakening in the inflow of cash from core operations in the most recent years.
- Investing Activities
- Cash flows from investing activities have consistently been negative throughout the period, reflecting ongoing investments. There are several pronounced spikes in outflows, notably in 2006 (-$4,593 million), 2008 (-$4,581 million), 2014 (-$13,420 million), and a dramatic surge in 2018 (-$43,285 million). The sizable investing outflow in 2018 represents a significant capital expenditure or acquisitions event. After that year, investment outflows moderate but remain substantial, with still large negative cash flows of -$20,889 million in 2022 and decreasing to -$7,613 million in 2024, indicating continued investment activities but at reduced levels compared to the peak.
- Financing Activities
- Net cash flows from financing activities display more volatility and frequent changes in direction. Early years show mixed values, with periods of cash inflows and outflows. A notable inflow of $2,868 million occurs in 2006, and the largest inflow by far is recorded in 2018 at $36,819 million, closely aligned with the large investing cash outflows of the same year, suggesting financing to support major investments or acquisitions. After 2018, the cash flows from financing revert mostly to outflows, with sizable negative amounts in 2019 (-$7,850 million), 2020 (-$8,155 million), 2021 (-$11,356 million), and 2022 (-$10,516 million). The years 2023 and 2024 show net cash inflows of $2,683 million and outflows of -$1,135 million respectively, indicating a somewhat irregular financing pattern in the recent period.
- Summary of Trends
- The overall financial cash flow pattern reveals a company generating increasing operating cash flow for most of the examined period, which supports substantial investment activities reflected in persistently negative investing cash flows. The significant spikes in investing outflows and matching large financing inflows during 2018 suggest a major strategic expenditure funded by external capital. Subsequently, the company appears to shift toward repaying debt or reducing external financing, as evidenced by consistent financing outflows from 2019 onward. The recent downturn in operating cash inflows raises questions about operational efficiency or external factors impacting cash generation. Additionally, the continued investing outflows, albeit reduced, indicate ongoing capital deployment. The fluctuations in financing cash flows emphasize dynamic capital structure decisions possibly influenced by strategic initiatives and market conditions.
Per Share Data
12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
---|---|---|---|
Dec 31, 2024 | |||
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 29, 2007 | |||
Dec 30, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.
The analysis of the earnings per share (EPS) and dividend per share data over the period from December 31, 2005, to December 31, 2024, reveals several notable patterns and shifts.
- Basic Earnings Per Share (EPS)
- The basic EPS showed a generally upward trend from 1.49 USD in 2005 to a peak of 6.47 USD in 2017. This growth reflects a consistent improvement in profitability over most of the timeframe. However, in 2018, there was a significant downturn, with the EPS dropping to -0.57 USD, indicating a loss for that year. Following this decline, the EPS recovered strongly in subsequent years, reaching 5.10 USD in 2019 and peaking again at 6.00 USD in 2021. Another decline occurred in 2022, reducing EPS to 3.16 USD, but it rebounded to 6.49 USD in 2023. The most recent figure for 2024 shows a drop to 3.67 USD, indicating volatility in recent years.
- Diluted Earnings Per Share
- The diluted EPS closely mirrors the trend of the basic EPS, suggesting that dilution effects remained relatively stable over the years. It increased from 1.45 USD in 2005 to a high of 6.47 USD in 2017, followed by the same sharp decrease to -0.57 USD in 2018. Recovery continued similarly, with diluted EPS reaching 5.95 USD in 2021, declining to 3.14 USD in 2022, rebounding to 6.47 USD in 2023, and then dropping again to 3.66 USD in 2024.
- Dividend Per Share
- The dividend per share exhibited a steady and almost uninterrupted increase over the period. Starting at 0.15 USD in 2005, the dividends consistently rose year-over-year, reaching 2.00 USD in 2017 and maintaining that level through 2021. From 2022 onward, the dividends increased further, reaching 2.66 USD by 2024. Notably, this upward trend in dividends persisted even during periods when earnings experienced declines or volatility, signaling a strong commitment to returning value to shareholders.
- Insights and Observations
- The data reflects a company with historically strong growth in profitability, as evidenced by the rising earnings per share up to 2017. The sharp drop in 2018 suggests an isolated adverse event or challenging market conditions impacting earnings. The subsequent volatility in EPS from 2018 onward indicates a period of instability or restructuring. Despite these fluctuations in earnings, the company maintained and even increased dividend payments, which may imply confidence in future cash flows or a strategic focus on shareholder returns. The divergence between the trends of EPS and dividends in the latter years may warrant further investigation into the underlying causes and sustainability of payout policies.